These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38892254)

  • 1. Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo.
    Jiang WP; Deng JS; Yu CC; Lin JG; Huang GJ
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sun TK; Huang WC; Sun YW; Deng JS; Chien LH; Chou YN; Jiang WP; Lin JG; Huang GJ
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.
    Choi Y; Shin B; Kang K; Park S; Beck BR
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
    Muralidar S; Gopal G; Visaga Ambi S
    J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harringtonine metabolites: 5'-de-O-methylharringtonine and cephalotaxine, targeting spike protein and TMPRSS2 to double block membrane fusion of SARS-CoV-2 and its variants.
    Gao J; Hu S; Ma X; Zhang Y; Ren B; Lei P; Ma W; He L
    Eur J Pharmacol; 2024 Nov; 983():177012. PubMed ID: 39304111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Qu B; Miskey C; Gömer A; Kleinert RDV; Ibanez SC; Eberle R; Ebenig A; Postmus D; Nocke MK; Herrmann M; Itotia TK; Herrmann ST; Heinen N; Höck S; Hastert FD; von Rhein C; Schürmann C; Li X; van Zandbergen G; Widera M; Ciesek S; Schnierle BS; Tarr AW; Steinmann E; Goffinet C; Pfaender S; Locker JK; Mühlebach MD; Todt D; Brown RJP
    Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2407437121. PubMed ID: 38814864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
    Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
    J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro.
    Unal MA; Bitirim CV; Summak GY; Bereketoglu S; Cevher Zeytin I; Besbinar O; Gurcan C; Aydos D; Goksoy E; Kocakaya E; Eran Z; Murat M; Demir N; Aksoy Ozer ZB; Somers J; Demir E; Nazir H; Ozkan SA; Ozkul A; Azap A; Yilmazer A; Akcali KC
    Can J Physiol Pharmacol; 2021 May; 99(5):449-460. PubMed ID: 33689451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.
    Williams N; Silva F; Schmolke M
    Antiviral Res; 2024 Aug; 228():105951. PubMed ID: 38945485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus.
    Kumar V; Sari AN; Meidinna HN; Dhanjal JK; Subramani C; Basu B; Kaul SC; Vrati S; Sundar D; Wadhwa R
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34647577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
    Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection.
    Cheng FJ; Huynh TK; Yang CS; Hu DW; Shen YC; Tu CY; Wu YC; Tang CH; Huang WC; Chen Y; Ho CY
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
    Gupta VK; Murthy MK; Patil S
    Curr Drug Targets; 2021; 22(10):1149-1157. PubMed ID: 33243116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
    Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17β-estradiol reduces SARS-CoV-2 infection in vitro.
    Lemes RMR; Costa AJ; Bartolomeo CS; Bassani TB; Nishino MS; Pereira GJDS; Smaili SS; Maciel RMB; Braconi CT; da Cruz EF; Ramirez AL; Maricatto JT; Janini LMR; Prado CM; Stilhano RS; Ureshino RP
    Physiol Rep; 2021 Jan; 9(2):e14707. PubMed ID: 33463909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.